HLA-F and MHC-I open conformers bind natural killer cell ig-like receptor KIR3DS1

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Burian, Aura ^a   Wang, Kevin L ^a   Finton, Kathryn A K ^a   Lee, Ni ^a   Ishitani, Akiko ^b   Strong, Roland K ^a   Geraghty, Daniel E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA F ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT PROTEIN; HLA ANTIGEN CLASS 1; HLA-F ANTIGENS; PROTEIN BINDING;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; INFLAMMATION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; CYTOLOGY; METABOLISM; MOLECULAR MODEL; MONONUCLEAR CELL; PROTEIN FOLDING;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN FOLDING; RECEPTORS, KIR3DS1;

EID: 84991577928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163297     Document Type: Article

References (28)

1. Blum JS, Wearsch PA, Cresswell P, Pamer E, Cresswell P. Pathways of antigen processing Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 2013; 31:443-73. Epub 2013/01/10 1998/05/23. doi: 10.1146/annurev-immunol-032712-095910 PMID: 23298205.
2. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2012; 367(1590):800-11.
3. Epub 2012/02/09. doi: 10.1098/rstb.2011.0266 PMID: 22312047; PubMed Central PMCID: PMC3267113.
4. Velardi A, Ruggeri L, Mancusi A. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. Current opinion in hematology. 2012; 19(4):319-23. Epub 2012/05/05. doi: 10. 1097/MOH.0b013e32835423c3 PMID: 22555394.
5. Male V, Trundley A, Gardner L, Northfield J, Chang C, Apps R, et al. Natural killer cells in human pregnancy. Methods in molecular biology. 2010; 612:447-63. Epub 2009/12/25. doi: 10.1007/978-1-60761-362-6-30 PMID: 20033659.
6. Bashirova AA, Thomas R, Carrington M. HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol. 2011; 29:295-317. Epub 2011/01/12. doi: 10.1146/annurev-immunol-031210-101332 PMID: 21219175; PubMed Central PMCID: PMC3725604.
7. Rajagopalan S, Long EO. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol. 2012; 3:258. Epub 2012/08/31. doi: 10.3389/fimmu.2012.00258 PMID: 22934097; PubMed Central PMCID: PMC3422731.
8. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A. 1998; 95(9):5199-204. PMID: 9560253
9. Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol. 2010; 184(11):6199-208. Epub 2010/05/21. doi: 10. 4049/jimmunol.1000078 PMID: 20483783; PubMed Central PMCID: PMC3777411.
10. Lee N, Ishitani A, Geraghty DE. HLA-F is a surface marker on activated lymphocytes. Eur J Immunol. 2010; 40(8):2308-18. Epub 2010/09/25. PMID: 20865824.
11. Goodridge JP, Lee N, Burian A, Pyo CW, Tykodi SS, Warren EH, et al. HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol. 2013; 191(4):1567-77. Epub 2013/07/16. doi: 10.4049/jimmunol.1300080 PMID: 23851683; PubMed Central PMCID: PMC3732835.
12. Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors. J Immunol. 2013; 191(7):3553-62. Epub 2013/09/11. doi: 10.4049/ jimmunol.1300081 PMID: 24018270; PubMed Central PMCID: PMC3780715.
13. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, et al. Killer cell immunoglobulinlike receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature. 2011; 479(7373):401-5. Epub 2011/10/25. doi: 10.1038/nature10517 PMID: 22020283; PubMed Central PMCID: PMC3723390.
14. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, et al. Cutting Edge: Allelespecific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2007; 178(1):33-7. PMID: 17182537.
15. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, et al. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol. 2011; 85(12):5970-4. doi: 10.1128/JVI.00412-11 PMID: 21471246; PubMed Central PMCID: PMC3126328.
16. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ ILT4/CD85d). Proc Natl Acad Sci U S A. 2006; 103(44):16412-7. PMID: 17056715.
17. Morvan M, Willem C, Gagne K, Kerdudou N, David G, Sebille V, et al. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J Immunol. 2009; 182(11):6727-35. doi: 10. 4049/jimmunol.0900212 PMID: 19454667.
18. Pascal V, Yamada E, MartinMP, Alter G, Altfeld M, Metcalf JA, et al. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol. 2007; 179(3):1625-33. PMID: 17641029
19. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol. 2011; 187(1):11-9. doi: 10.4049/jimmunol.0902332 PMID: 21690332; PubMed Central PMCID: PMC3223120.
20. Single RM, MartinMP, Gao X, Meyer D, Yeager M, Kidd JR, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet. 2007; 39(9):1114-9. doi: 10.1038/ng2077 PMID: 17694058.
21. Martin MP, Carrington M. Immunogenetics of HIV disease. Immunol Rev. 2013; 254(1):245-64. doi: 10. 1111/imr.12071 PMID: 23772624; PubMed Central PMCID: PMC3703621.
22. Carrington M, Alter G. Innate immune control of HIV. Cold Spring Harb Perspect Med. 2012; 2(7): a007070. doi: 10.1101/cshperspect.a007070 PMID: 22762020; PubMed Central PMCID: PMC3385945.
23. Finton KA, Strong RK. Structural insights into activation of antiviral NK cell responses. Immunol Rev. 2012; 250(1):239-57. doi: 10.1111/j.1600-065X.2012.01168.x PMID: 23046134; PubMed Central PMCID: PMC3471384.
24. Chazara O, Xiong S, Moffett A. MaternalKIR and fetal HLA-C: a fine balance. J Leukoc Biol. 2011; 90 (4):703-16. Epub 2011/08/30. doi: 10.1189/jlb.0511227 PMID: 21873457.
25. Lash GE, Robson SC, Bulmer JN. Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta. 2010; 31 Suppl:S87-92. Epub 2010/01/12. doi: 10.1016/j.placenta. 2009.12.022 PMID: 20061017.
26. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003; 171(3):1376-84. Epub 2003/07/23. PMID: 12874228.
27. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med. 2003; 198 (8):1201-12. Epub 2003/10/22. doi: 10.1084/jem.20030305 jem.20030305 [pii]. PMID: 14568979; PubMed Central PMCID: PMC2194228.
28. Garcia-Beltran WF, Holzemer A, MartrusG, Chung AW, Pacheco Y, Simoneau CR, et al. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol. 2016; 17(9):1067-74. doi: 10.1038/ni.3513 PMID: 27455421; PubMed Central PMCID: PMCPMC4992421.